Rare Germline ATM Variants Influence the Development of Chronic Lymphocytic Leukemia
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F23%3A73614534" target="_blank" >RIV/61989592:15110/23:73614534 - isvavai.cz</a>
Result on the web
<a href="https://ascopubs.org/doi/pdf/10.1200/JCO.22.00269?role=tab" target="_blank" >https://ascopubs.org/doi/pdf/10.1200/JCO.22.00269?role=tab</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1200/JCO.22.00269" target="_blank" >10.1200/JCO.22.00269</a>
Alternative languages
Result language
angličtina
Original language name
Rare Germline ATM Variants Influence the Development of Chronic Lymphocytic Leukemia
Original language description
PURPOSE Germline missense variants of unknown significance in cancer-related genes are increasingly beingidentified with the expanding use of next-generation sequencing. The ataxia telangiectasia–mutated (ATM) geneon chromosome 11 has more than 1,000 germline missense variants of unknown significance and is a tumorsuppressor. We aimed to determine if rare germline ATM variants are more frequent in chronic lymphocyticleukemia (CLL) compared with other hematologic malignancies and if they influence the clinical characteristicsof CLL.METHODS We identified 3,128 patients (including 825 patients with CLL) in our hematologic malignancy clinicwho had received clinical-grade sequencing of the entire coding region of ATM.We ascertained the comparativefrequencies of germline ATM variants in categories of hematologic neoplasms, and, in patients with CLL, wedetermined whether these variants affected CLL-associated characteristics such as somatic 11q deletion.RESULTS Rare germline ATM variants are present in 24% of patients with CLL, significantly greater than that inpatients with other lymphoid malignancies (16% prevalence), myeloid disease (15%), or no hematologicneoplasm (14%). Patients with CLL with germline ATM variants are younger at diagnosis and twice as likely tohave 11q deletion. The ATM variant p.L2307F is present in 3% of patients with CLL, is associated with a threefoldincrease in rates of somatic 11q deletion, and is a hypomorph in cell-based assays.CONCLUSION Germline ATM variants cluster within CLL and affect the phenotype of CLL that develops, implyingthat some of these variants (such as ATM p.L2307F) have functional significance and should not be ignored.Further studies are needed to determine whether these variants affect the response to therapy or account forsome of the inherited risk of CLL.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
JOURNAL OF CLINICAL ONCOLOGY
ISSN
0732-183X
e-ISSN
1527-7755
Volume of the periodical
41
Issue of the periodical within the volume
5
Country of publishing house
US - UNITED STATES
Number of pages
13
Pages from-to
1116-1128
UT code for WoS article
000946950600022
EID of the result in the Scopus database
2-s2.0-85147720497